Noninvasive Imaging of Endothelial Damage in Patients With Different HbA 1c Levels: A Proof-of-Concept Study

The aim of this study was to compare endothelial permeability, which is considered a hallmark of coronary artery disease, between patients with different HbA levels using an albumin-binding magnetic resonance (MR) probe. This cross-sectional study included 26 patients with clinical indication for X-...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 68; no. 2; p. 387
Main Authors Engel, Leif-Christopher, Landmesser, Ulf, Goehler, Alexander, Gigengack, Kevin, Wurster, Thomas-Heinrich, Manes, Costantina, Girke, Georg, Jaguszewski, Milosz, Skurk, Carsten, Leistner, David M, Lauten, Alexander, Schuster, Andreas, Noutsias, Michel, Hamm, Bernd, Botnar, Rene M, Bigalke, Boris, Makowski, Marcus R
Format Journal Article
LanguageEnglish
Published United States 01.02.2019
Online AccessGet full text
ISSN1939-327X
DOI10.2337/db18-0239

Cover

Abstract The aim of this study was to compare endothelial permeability, which is considered a hallmark of coronary artery disease, between patients with different HbA levels using an albumin-binding magnetic resonance (MR) probe. This cross-sectional study included 26 patients with clinical indication for X-ray angiography who were classified into three groups according to HbA level (<5.7% [<39 mmol/mol], 5.7-6.4% [39-47 mmol/mol], and ≥6.5% [48 mmol/mol]). Subjects underwent gadofosveset-enhanced coronary magnetic resonance and X-ray angiography including optical coherence within 24 h. Contrast-to-noise ratios (CNRs) were assessed to measure the probe uptake in the coronary wall by coronary segment, excluding those with culprit lesions in X-ray angiography. In the group of patients with HbA levels between 5.7 and 6.4%, 0.30 increased normalized CNR values were measured, compared with patients with HbA levels <5.7% (0.30 [95% CI 0.04, 0.57]). In patients with HbA levels ≥6.5%, we found 0.57 higher normalized CNR values compared with patients with normal HbA levels (0.57 [95% CI 0.28, 0.85]) and 0.26 higher CNR values for patients with HbA level ≥6.5% compared with patients with HbA levels between 5.7 and 6.4% (0.26 [95% CI -0.04, 0.57]). Additionally, late atherosclerotic lesions were more common in patients with high HbA levels (HbA ≥6.5%, = 14 [74%]; HbA 5.7-6.4%, = 6 [60%]; and HbA <5.7%, = 10 [53%]). In conclusion, coronary MRI in combination with an albumin-binding MR probe suggests that both patients with intermediate and patients with high HbA levels are associated with a higher extent of endothelial damage of the coronary arteries compared with patients with HbA levels <5.7%.
AbstractList The aim of this study was to compare endothelial permeability, which is considered a hallmark of coronary artery disease, between patients with different HbA levels using an albumin-binding magnetic resonance (MR) probe. This cross-sectional study included 26 patients with clinical indication for X-ray angiography who were classified into three groups according to HbA level (<5.7% [<39 mmol/mol], 5.7-6.4% [39-47 mmol/mol], and ≥6.5% [48 mmol/mol]). Subjects underwent gadofosveset-enhanced coronary magnetic resonance and X-ray angiography including optical coherence within 24 h. Contrast-to-noise ratios (CNRs) were assessed to measure the probe uptake in the coronary wall by coronary segment, excluding those with culprit lesions in X-ray angiography. In the group of patients with HbA levels between 5.7 and 6.4%, 0.30 increased normalized CNR values were measured, compared with patients with HbA levels <5.7% (0.30 [95% CI 0.04, 0.57]). In patients with HbA levels ≥6.5%, we found 0.57 higher normalized CNR values compared with patients with normal HbA levels (0.57 [95% CI 0.28, 0.85]) and 0.26 higher CNR values for patients with HbA level ≥6.5% compared with patients with HbA levels between 5.7 and 6.4% (0.26 [95% CI -0.04, 0.57]). Additionally, late atherosclerotic lesions were more common in patients with high HbA levels (HbA ≥6.5%, = 14 [74%]; HbA 5.7-6.4%, = 6 [60%]; and HbA <5.7%, = 10 [53%]). In conclusion, coronary MRI in combination with an albumin-binding MR probe suggests that both patients with intermediate and patients with high HbA levels are associated with a higher extent of endothelial damage of the coronary arteries compared with patients with HbA levels <5.7%.
Author Jaguszewski, Milosz
Skurk, Carsten
Leistner, David M
Goehler, Alexander
Wurster, Thomas-Heinrich
Makowski, Marcus R
Bigalke, Boris
Hamm, Bernd
Schuster, Andreas
Lauten, Alexander
Girke, Georg
Manes, Costantina
Noutsias, Michel
Botnar, Rene M
Engel, Leif-Christopher
Landmesser, Ulf
Gigengack, Kevin
Author_xml – sequence: 1
  givenname: Leif-Christopher
  orcidid: 0000-0002-6079-9913
  surname: Engel
  fullname: Engel, Leif-Christopher
  email: leifengel@hotmail.com
  organization: Berlin Institute of Health, Berlin, Germany
– sequence: 2
  givenname: Ulf
  surname: Landmesser
  fullname: Landmesser, Ulf
  organization: German Centre for Cardiovascular Research (DZHK), partner site Berlin, Germany
– sequence: 3
  givenname: Alexander
  surname: Goehler
  fullname: Goehler, Alexander
  organization: Department of Radiology, Brigham's and Women Hospital and Harvard Medical School, Boston, MA
– sequence: 4
  givenname: Kevin
  surname: Gigengack
  fullname: Gigengack, Kevin
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 5
  givenname: Thomas-Heinrich
  surname: Wurster
  fullname: Wurster, Thomas-Heinrich
  organization: Berlin Institute of Health, Berlin, Germany
– sequence: 6
  givenname: Costantina
  surname: Manes
  fullname: Manes, Costantina
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 7
  givenname: Georg
  surname: Girke
  fullname: Girke, Georg
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 8
  givenname: Milosz
  surname: Jaguszewski
  fullname: Jaguszewski, Milosz
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 9
  givenname: Carsten
  surname: Skurk
  fullname: Skurk, Carsten
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 10
  givenname: David M
  surname: Leistner
  fullname: Leistner, David M
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 11
  givenname: Alexander
  surname: Lauten
  fullname: Lauten, Alexander
  organization: German Centre for Cardiovascular Research (DZHK), partner site Berlin, Germany
– sequence: 12
  givenname: Andreas
  surname: Schuster
  fullname: Schuster, Andreas
  organization: Department of Cardiology, Royal North Shore Hospital, The Kolling Institute, Nothern Clinical School, University of Sydney, Sydney, Australia
– sequence: 13
  givenname: Michel
  surname: Noutsias
  fullname: Noutsias, Michel
  organization: Mid-German Heart Center, Division of Cardiology, Angiology and Intensive Medical Care, Department of Internal Medicine III, University Hospital Halle, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
– sequence: 14
  givenname: Bernd
  surname: Hamm
  fullname: Hamm, Bernd
  organization: Klinik für Radiologie, Charité - Universitätsmedizin Berlin, Berlin, Germany
– sequence: 15
  givenname: Rene M
  surname: Botnar
  fullname: Botnar, Rene M
  organization: Division of Imaging Sciences and Biomedical Engineering, King's College London, London, U.K
– sequence: 16
  givenname: Boris
  surname: Bigalke
  fullname: Bigalke, Boris
  organization: Klinik für Kardiologie, Charité Campus Benjamin Franklin, Universitätsmedizin Berlin, Berlin, Germany
– sequence: 17
  givenname: Marcus R
  surname: Makowski
  fullname: Makowski, Marcus R
  organization: Klinik für Radiologie, Charité - Universitätsmedizin Berlin, Berlin, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30487264$$D View this record in MEDLINE/PubMed
BookMark eNo1T11LAzEQDKLYD33wD8j-gdPc7TW586201RaKFizoW0maTRu5JsddWui_90Rlh1l2YIbZAbv0wRNjdyl_yBDlo9FpkfAMywvWT0ssE8zkZ48N2vaLcy66uWY95HkhM5H3WfUavPMn1boTweKgds7vIFiYeRPiniqnKpiqTidwHlYqOvKxhQ8X9zB11lLT3TDXY0i3sKQTVe0TjGHVhGCTDpPgt1RHeI9Hc75hV1ZVLd3-7SFbP8_Wk3myfHtZTMbLpC4xJpnVuSREM0KrMctIaKWMFEpqmVLXnCR1hNYUJBTfFlzkqpQ65SOBP84hu_-NrY_6QGZTN-6gmvPm_2v8BvvuWFo
ContentType Journal Article
Copyright 2018 by the American Diabetes Association.
Copyright_xml – notice: 2018 by the American Diabetes Association.
DBID NPM
DOI 10.2337/db18-0239
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
ExternalDocumentID 30487264
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: British Heart Foundation
  grantid: PG/10/044/28343
– fundername: British Heart Foundation
  grantid: RG/12/1/29262
GroupedDBID ---
.55
.GJ
.XZ
08P
0R~
18M
1CY
29F
2WC
354
4.4
53G
5GY
5RE
5RS
5VS
6PF
7RV
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAFWJ
AAKAS
AAQQT
AAWTL
AAYEP
AAYJJ
ABOCM
ABUWG
ACGFO
ACGOD
ACPRK
ADBBV
ADGHP
ADZCM
AEGXH
AENEX
AERZD
AFFNX
AFKRA
AHMBA
AI.
AIAGR
AIZAD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BTFSW
BVXVI
C1A
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FRP
FYUFA
GICCO
GNUQQ
GUQSH
GX1
H13
HCIFZ
HMCUK
HZ~
H~9
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
ITC
J5H
K-O
K2M
K9-
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5~
M7P
MVM
N4W
NAPCQ
NPM
O5R
O5S
O9-
OB3
OHH
OK1
OVD
P2P
PCD
PEA
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
TEORI
TR2
UKHRP
VH1
VVN
W8F
WH7
WOQ
WOW
X7M
XOL
YFH
YHG
YOC
YQJ
ZGI
ZXP
ZY1
~KM
ID FETCH-LOGICAL-p93t-2fb47e33d53fb322e6baad76a7b71e048e7e48e3fd8e6a0c8064a97b1056347e3
IngestDate Mon Jul 21 05:58:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2018 by the American Diabetes Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p93t-2fb47e33d53fb322e6baad76a7b71e048e7e48e3fd8e6a0c8064a97b1056347e3
ORCID 0000-0002-6079-9913
PMID 30487264
ParticipantIDs pubmed_primary_30487264
PublicationCentury 2000
PublicationDate 2019-02-00
PublicationDateYYYYMMDD 2019-02-01
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-02-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2019
SSID ssj0006060
Score 2.320264
Snippet The aim of this study was to compare endothelial permeability, which is considered a hallmark of coronary artery disease, between patients with different HbA...
SourceID pubmed
SourceType Index Database
StartPage 387
Title Noninvasive Imaging of Endothelial Damage in Patients With Different HbA 1c Levels: A Proof-of-Concept Study
URI https://www.ncbi.nlm.nih.gov/pubmed/30487264
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZC6UvY-vuN_Swt-AutmzJ3ltoMtIre0hp3opkSyWQOGFz97D3_e-dI9mqajbYCkEYyxei83F0dHy-T4R8zA1jKhNpxLhkUSoN-EGVpXCE1OtY5cpgHvL8gs8u05NFthgMfgVVS7eNOix__pFX8hCrwjmwK7Jk_8Oy_qFwAo7BvtCChaH9JxtfYC71h7QV6Mfrdr8hM5zWFfKqVpgMn8g1VuUsaxTjX1o62xWmXiftxijNcKbGw7gcnmH10HdHVP8K4bSJ4HfkSI222vDe999JkLLtb-YTJBemWDJrl_56CU-7EzLwdUCyrtZWvhyvulwZXw-00d2-zJ6D4_tQQfRGOkd-CjN7HeYukC7l60C087cFKyKWiEXokHkeAC8JvCtzc3Pf6yfM6gZUKs4j5OqG18CwbdfW_Ax8lUicZHpPYrvrekR2EyHc1_7jUz-hwxpv5ESp8E2f_Hv2yV53Z29RYoOT-RPyuF1V0LGDyFMy0PUB2Ttv6yaekVWAFNoihW4MDZBCHVLosqYdUigihXqkUEAKjUvqkPKZjmkfJ9Ti5DmZf5nOj2ZRu89GtC1YEyVGpUIzVmXMKPDvmispK8GlUCLW8Ae10NAwU-Way1GZQxQrC6EgMucM73xBdupNrV8RylFqSBompZHpKBEyzkqId3hVQRQpCvOavHTDdL11WirX3QC--WvPW7J_B513ZKf5dqvfQyDYqA_WTL8BwtldGw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Noninvasive+Imaging+of+Endothelial+Damage+in+Patients+With+Different+HbA+1c+Levels%3A+A+Proof-of-Concept+Study&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Engel%2C+Leif-Christopher&rft.au=Landmesser%2C+Ulf&rft.au=Goehler%2C+Alexander&rft.au=Gigengack%2C+Kevin&rft.date=2019-02-01&rft.eissn=1939-327X&rft.volume=68&rft.issue=2&rft.spage=387&rft_id=info:doi/10.2337%2Fdb18-0239&rft_id=info%3Apmid%2F30487264&rft.externalDocID=30487264